ERBB2 and metastatic malignant neoplasm in the lymph nodes: The results of the univariate COX regression analysis showed that lymph node metastasis, tumor diameter, and Ki67 expression were risk factors affecting the 5-year DFS rates in patients with ultra-low HER-2 expression (P < 0.05; Table 3).